A calm, supportive guide for patients living with Allergic Bronchopulmonary Aspergillosis (ABPA)
Allergic Bronchopulmonary Aspergillosis (ABPA) can be confusing.
Some people hear “fungus” and think it is a dangerous infection.
Others hear “allergy” and think it has nothing to do with fungi at all.
The truth is somewhere in the middle — and understanding this can make your treatment feel much clearer and less frightening.
This article explains:
-
Whether ABPA is an infection, an allergy, or both
-
How the fungus Aspergillus fumigatus fits into the picture
-
Why biologics help — and whether they allow the fungus to grow
-
Why your future with ABPA is more hopeful than ever
🌼 1. Is ABPA an infection or an allergic over-reaction?
The simplest explanation is:
ABPA happens when Aspergillus lives in mucus in the airways, and the immune system overreacts. It’s driven by allergy, not by fungal invasion.
In ABPA:
-
Aspergillus fumigatus sits in mucus, especially in asthma, bronchiectasis or cystic fibrosis
-
It does not invade or damage lung tissue
-
The immune system becomes over-sensitised and reacts too strongly
This allergic reaction triggers:
-
Very high IgE
-
High eosinophils
-
Swelling, tightness, wheeze
-
Thick “stringy” mucus or plugs
-
Repeated flare-ups that feel like chest infections
The inflammation — not the fungus — is what damages the lungs over time.
🌻 2. If it’s not a typical infection, why treat the fungus?
Even though ABPA is allergic, reducing fungal load can still help.
Here’s why:
-
Less fungus in mucus → less allergen
-
Less allergen → less immune reaction
-
Less reaction → fewer flare-ups, better breathing
This is why some people take antifungals.
But antifungals are not always necessary, especially today with the arrival of biologics.
🌈 3. Do biologics weaken the immune system and let the fungus grow?
No.
This is a very common worry — but the biologics used for ABPA do not suppress the parts of the immune system that keep you safe from fungi.
Biologics such as:
-
Omalizumab (anti-IgE)
-
Mepolizumab / Benralizumab (anti-IL-5)
-
Dupilumab (anti-IL-4/IL-13)
-
Tezepelumab (anti-TSLP)
target overactive allergic pathways, not antifungal defences.
They do not affect:
-
Neutrophils
-
Macrophages
-
Dectin-1
-
TLR antifungal pathways
-
Complement
These are the real fungus-clearing systems — and biologics leave them intact.
🍃 4. Do biologics actually help clear fungus? Surprisingly, sometimes yes.
Many patients on biologics show:
-
Fewer mucus plugs
-
Better airflow
-
Fewer positive sputum cultures
-
Reduced symptoms
-
Lower exacerbation rates
-
Less need for steroids or antifungals
When mucus plugs shrink, fungus loses its hiding place.
Your natural defences can finally clear it.
So biologics do not encourage growth — they may even help reduce fungal load.
🌺 5. Why are outcomes improving so much?
ABPA used to be a condition dominated by:
-
frequent flare-ups
-
repeated steroids
-
fear of lung damage
-
long periods of being unwell
Today, with biologics:
-
far fewer flare-ups
-
easier breathing
-
more stable lung function
-
much less steroid use
-
better quality of life
-
higher confidence and control
For many patients, biologics are transforming ABPA from a cycle of crises into a more manageable long-term condition.
🌼 6. Key reassurance
If you remember only one sentence, let it be this:
Biologics calm the allergic response that causes ABPA, without weakening your natural ability to clear fungus — and many patients do better than ever on them.
🌟 7. Moving forward with confidence
ABPA is complex, but it is treatable, manageable, and increasingly well-understood.
You are not dealing with a dangerous lung infection — you are dealing with an over-active immune response that modern treatments can control.
With the right support, airway clearance, the best inhalers, and (where needed) biologics or antifungals, most people:
-
stabilise
-
breathe more easily
-
reduce flare-ups
-
protect their lungs
-
live full, active lives
You’re not alone — and the future for ABPA care has never looked brighter.
Share this post
Latest News posts
Why Headaches Can Occur in Aspergillosis
March 30, 2026
Why Do My “Histamine” Headaches Improve on Itraconazole?
March 30, 2026
Aspergillosis in Pets: A Practical Guide for Owners
March 25, 2026
Donating Your Body for Medical Research in the UK
March 24, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
